<p>*The number of non-observed HIV-positive individuals was estimated under the assumption that there was no selection bias, i.e., the observed HIV prevalence of 30.5% was applied to individuals whose HIV status was not observed within TasP. The 2,983 amongst the HIV-infected individuals in column 1 refers to the total number of individuals ascertained as HIV-positive within TasP in both arms of the trial, 2,569 (<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1002107#pmed.1002107.g001" target="_blank">Fig 1</a>), plus those who declined HIV rapid test but whose DBS HIV ELISA was positive and matched that of 137 individuals on ART within the DoH clinics.</p
Introduction: HIV testing is a cornerstone of efforts to combat the HIV epidemic, and testing conduc...
<p>This figure is based on data from <a href="http://www.plosmedicine.org/article/info:doi/10.1371/j...
<p>Observed and Predicted HIV prevalence among: A) all FSW nationalities combined, B) clients, C) al...
We develop a new approach for estimating the undiagnosed fraction of HIV cases, the first step in th...
<p>Scenarios as for <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0030...
Objective: To estimate the prevalence of undiagnosed HIV, the prevalence of diagnosed HIV, and propo...
BACKGROUND AND OBJECTIVES: Population attributable fractions (PAF) from observational studies may un...
(See the major article by Laeyendecker et al, on pages 232–9 and the editorial commentary by Mastro,...
<p><sup>*</sup> IAVI support initiated in 2004</p><p><sup>**</sup> p value for the incident rate rat...
<div><p>Background</p><p>National Institute of Mental Health Project Accept (HIV Prevention Trials N...
a<p>Excludes participants who were not contacted, declined participation, or did not meet enrollment...
Introduction: Successful global treatment as prevention (TasP) requires identifying HIV-positive ind...
Introduction: HIV testing is a cornerstone of efforts to combat the HIV epidemic, and testing conduc...
OBJECTIVES: To describe the HIV care cascade for Switzerland in the year 2012. DESIGN/METHODS: Six l...
<p>This figure shows HIV prevalence in HIVST participants for men (A) and women (B), stratified by t...
Introduction: HIV testing is a cornerstone of efforts to combat the HIV epidemic, and testing conduc...
<p>This figure is based on data from <a href="http://www.plosmedicine.org/article/info:doi/10.1371/j...
<p>Observed and Predicted HIV prevalence among: A) all FSW nationalities combined, B) clients, C) al...
We develop a new approach for estimating the undiagnosed fraction of HIV cases, the first step in th...
<p>Scenarios as for <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0030...
Objective: To estimate the prevalence of undiagnosed HIV, the prevalence of diagnosed HIV, and propo...
BACKGROUND AND OBJECTIVES: Population attributable fractions (PAF) from observational studies may un...
(See the major article by Laeyendecker et al, on pages 232–9 and the editorial commentary by Mastro,...
<p><sup>*</sup> IAVI support initiated in 2004</p><p><sup>**</sup> p value for the incident rate rat...
<div><p>Background</p><p>National Institute of Mental Health Project Accept (HIV Prevention Trials N...
a<p>Excludes participants who were not contacted, declined participation, or did not meet enrollment...
Introduction: Successful global treatment as prevention (TasP) requires identifying HIV-positive ind...
Introduction: HIV testing is a cornerstone of efforts to combat the HIV epidemic, and testing conduc...
OBJECTIVES: To describe the HIV care cascade for Switzerland in the year 2012. DESIGN/METHODS: Six l...
<p>This figure shows HIV prevalence in HIVST participants for men (A) and women (B), stratified by t...
Introduction: HIV testing is a cornerstone of efforts to combat the HIV epidemic, and testing conduc...
<p>This figure is based on data from <a href="http://www.plosmedicine.org/article/info:doi/10.1371/j...
<p>Observed and Predicted HIV prevalence among: A) all FSW nationalities combined, B) clients, C) al...